Skip to Main content Skip to Navigation
Journal articles

Imatinib Treatment of Chronic Myeloid Leukemia Reveals a Preexisting CALR-mutated Essential Thrombocythemia

Anaïse Blouet 1 Marie-Christine Rousselet 2, 3 yannick Le Bris 4, 5 Bénédicte Ribourtout 5, 3, 6 Anne Bouvier 5, 6 Laurane Cottin 7, 5, 6 Rebecca Jouanneau‐courville 5, 6 Odile Blanchet 7, 5, 6, 3 Valérie Ugo 7, 5, 6, 3 Damien Luque Paz 7, 5, 6, 3 
1 Service d'Oncologie Médicale [CH Cholet]
2 Laboratoire d’anatomopathologie [CHU Angers]
3 UFR Santé [UNIV Angers]
4 Laboratoire d'Hematologie [CHU Nantes]
5 FHU GOAL - Fédérations hospitalo-universitaires Grand Ouest Acute Leukemia [Angers]
6 Hémato - ANGERS - Laboratoire d'Hématologie Biologique
7 CRCINA-ÉQUIPE 7 - Innate Immunity and Immunotherapy
CRCINA - Centre de Recherche en Cancérologie et Immunologie Nantes-Angers
Document type :
Journal articles
Complete list of metadata

Cited literature [10 references]  Display  Hide  Download
https://www.hal.inserm.fr/inserm-02541794
Contributor : Elizabeth Bernardo Connect in order to contact the contributor
Submitted on : Tuesday, April 14, 2020 - 10:49:17 AM
Last modification on : Wednesday, April 27, 2022 - 3:42:30 AM

File

Vignette du document
2018_Bouet A_HemasphereEq7.pdf
Publication funded by an institution

Identifiers

Collections

INSERM | UNIV-NANTES | CNRS | UNIV-ANGERS | UNAM | CRCINA

Citation

Anaïse Blouet, Marie-Christine Rousselet, yannick Le Bris, Bénédicte Ribourtout, Anne Bouvier, et al.. Imatinib Treatment of Chronic Myeloid Leukemia Reveals a Preexisting CALR-mutated Essential Thrombocythemia. HemaSphere, Lippincott, Williams & Wilkins, 2018, 2 (1), pp.e29. ⟨10.1097/HS9.0000000000000029⟩. ⟨inserm-02541794⟩

Export

BibTeX TEI DC DCterms EndNote Datacite

Share

Metrics

Record views

41

Files downloads

36